The role of epithelial to mesenchymal transdifferentiation in end-stage renal disease

International Journal of Artificial Organs

Volumn 27, Issue 9, 2004, Pages 744-750

  Sam, Ramin ^a  

^a Jr Hospital of Cook County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

END-STAGE RENAL DISEASE; TRANSDIFFERENTIATION;

ALPHA SMOOTH MUSCLE ACTIN; BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN; CELL PROTEIN; EPIDERMAL GROWTH FACTOR; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

CELL DIFFERENTIATION; CELL TRANSFORMATION; EDITORIAL; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROGENESIS; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GLOMERULUS EPITHELIUM; HUMAN; HYPERINSULINEMIA; IN VITRO STUDY; IN VIVO STUDY; KIDNEY DISEASE; KIDNEY EPITHELIUM; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY TUBULE EPITHELIUM; LUPUS ERYTHEMATOSUS NEPHRITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SIGNAL TRANSDUCTION;

EID: 13644261781     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402700903     Document Type: Editorial

References (48)

1. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG. Identification and characterization of a fibroblast marker: FSP-1. J Cell Biol 1995; 130: 393-405.
2. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB. New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues. Proc Natl Acad Sci 1981; 78: 5339-43.
3. Choi ME. Mechanism of transforming growth factor-β1 signaling: role of the mitogen-activated protein kinase. Kidney Int 2000; 58 (suppl): S53-8.
4. Roberts AB, Piek E, Bottinger EP, Ashcroft G, Mitchell JB, Flanders KC. Is smad3 a major player in signal transduction pathways leading to fibrogenesis. Chest 2001; 120 (suppl): S43-7.
5. Healy E, Leonard M, Madrigal-Estebas L, O'Farrelly C, Watson AJ, Ryan MP. Factors produced by activated leukocytes alter renal epithelial cell differentiation. Kidney Int 1999; 56: 1266-9.
6. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falnaga V, Kehrl JH, Fauci AS. Proc Natl Acad Sci 1986; 83: 4167-71.
7. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci 1993; 90: 1814-8.
8. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 1990; 86: 453-62.
9. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY. Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999; 56: 1455-67.
10. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001; 159: 1465-75.
11. Tian YC, Phillips AO. Interaction between the transforming growth factor-β type II receptor/smad pathway and β-catenin during transforming growth factor-β1-mediated adherens junction disassembly. Am J Pathol 2002; 160: 1619-28.
12. Tian YC, Fraser D, Attisano L, Phillips AO. TGF-β1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am J Physiol Renal Physiol 2003; 285: F130-42.
13. Nightingale J, Patel S, Suzuki N, Buxton R, Takagi K, Suzuki J, Sumi Y, Imaizumi A, Mason RM, Zhang Z. Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. J Am Soc Nephrol 2004, 15: 21-32.
14. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S. Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 1993, 68: 154-63.
15. Sam R, Wanna L, Dunea G, Arruda JA, Singh AK. Transformation of glomerular epithelial cells into myofibroblasts with TGF-β is reversible initially, but becomes permanent with continued stimulation (Abstract). J Am Soc Nephrol 2003, 14: A123.
16. Abbate M, Zoja C, Morigi M, Rottoli D, Angioletti S, Tomasoni S, Zanchi C, Longaretti L, Donadelli R, Remuzzi G. Transforming growth factor-β1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins. Am J Pathol 2002, 161: 2179-93.
17. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990, 346: 371-4.
18. Niemir ZI, Stein H, Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R: PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 1995; 48: 1530-41.
19. Hayashida T, Poncelet AC, Hubchak SC, Schnaper HW. TGF-β1 activates MAP kinase in human mesangial cells: A possible role in collagen expression. Kidney Int 1999; 56: 1710-20.
20. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA. Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 1996; 49: 461-9.
21. Schnaper HW, Hayashida T, Poncelet AC. It's smad world: Regulation of TGF-beta signaling in the kidney. J Am Soc Nephrol 2002; 13: 1126-8.
22. Wadle EN. Renal fibrosis: Origin and potential of myofibroblasts. Nephron 2002; 92: 880-2.
23. Goumenos DS, Tsamandas AC, Nahas AME, Thomas G, Tsakas S, Sotsiou F, Bonikos DS, Vlachojannis JG. Apoptosis and myofibroblast expression in human glomerular disease: A possible link with transforming growth factor-beta-1. Nephron 2002; 92: 287-96.
24. Ng YY, Fan JM, Mu W, Nikolic-Paterson DJ, Yang WC, Huang TP, Atkin RC, Lan HY. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant 1999; 14: 2860-72.
25. Moeller MJ, Soofi A, Hartmann I, Le Hir M, Wiggins R, Kriz W, Holzman LB. Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 2004; 15: 61-7.
26. Jinde K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC, Lan HY. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 2001; 38: 761-9.
27. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic-Paterson DJ, Atkins RC, Lan HY. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998, 54: 864-76.
28. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive form epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-50.
29. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Hefferman JA, Aguilera A, Sanchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, Sanchez-Madrid F, Lopez-Cabrera M. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-13.
30. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004: 15: 1-12.
31. Martin J, Steadman R, Knowlden J, Williams J, Davies M. Differential regulation of matrix metalloproteinases and their inhibitors in human glomerular epithelial cells in vitro. J Am Soc Nephrol 1998; 9: 1629-37.
32. Boyer B, Valles AM, Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 2000; 60: 1091-9.
33. Yamashita S, Maeshima A, Kojima I, Nojima Y. Activin A is a potent activator of renal interstitial fibroblasts. J Am Soc Nephrol 2004; 15: 91-101.
34. Morrisey K, Evans RA, Wakefield L, Phillips AO. Translational regulation of renal proximal tubular epithelial cell transforming growth factor-β1 generation by insulin. Am J Pathol 2001; 159: 1905-15.
35. Yue J, Mulder KM. Transforming growth factor-β signal transduction in epithelial cells. Pharmacol Ther 2001; 91: 1-34.
36. Davidson G, Dono R, Zeller R. FGF signaling is required for differentiation-induced cytoskeletal reorganisation and formation of actin-based processes by podocytes. J Cell Sci 2001; 114: 3359-66.
37. Stutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Muller GA, Neilson EG. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 2002; 61: 1714-28.
38. Kaji H, Canaff L, Lebrun JJ, Goltzman D, Hendy GN. Inactivation of menin, a smad3-interacting protein, blocks transforming growth factor type β signaling. Proc Natl Acad Sci 2001; 98: 3837-42.
39. Itoh S, Itoh F, Goumans MJ, Dijke PT. Signaling of transforming growth factor-β family members through smad proteins. Eur J Biochem 2000; 267: 6954-67.
40. Zeisberg M, Hanai JI, Sugimoto H, Mammoto T, Charytan D, Stutz F, Kalluri R. BMP-7 counteracts TGF-β1-induced epithelial to mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-8.
41. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, Piek E, Bottinger EP. Genetic programs of epithelial cell plasticity directed by transforming growth factor-β. Proc Natl Acad Sci 2001; 98: 6686-91.
42. Poncelet AC, De Caestecker MP, Schnapper HW. The transforming growth factor-β/ smad pathway is present and functional in human mesangial cells. Kidney Int 1999; 56: 1354-65.
43. Nicolas FJ, Lehmann K, Warne PH, Hill CS, Downward J. Epithelial to mesenchymal transition in MDCK cells is accompanied by downregulation of smad3 expression leading to resistance to TGF-β-induced growth arrest. J Biol Chem 2003, 278: 3251-6.
44. Fujimoto M, Maezawa Y, Yokote K, Joh K, Kobayashi K, Kawamura H, Nishimura M, Roberts AB, Saito Y, Mori S. Mice lacking smad3 are protected against Streptozotocin-induced diabetic glomerulopathy. Biochem Biophys Res Commun 2003, 305: 1002-7.
45. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A. Targeted disruption of TGF-β1/smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003; 112: 1486-94.
46. Cheng S, Lovett DH. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 2003; 162: 1937-49.
47. Li Y, Yang J, Dai C, Wu C, Liu Y. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 2003; 112: 503-16.
48. Hay ED, Zuk A. Transformations between epithelium and mesenchyme: Normal, pathological, and experimentally induced. Am J Kidney Dis 1995; 26: 678-90.